Amgen Expands Indian Research Presence with New Genome Valley Centre

Global biotechnology company Amgen is expanding its research and scientific operations in India by establishing a Science and Innovation Center at Genome Valley in Hyderabad. The center will become part of Amgen's global Research and Development network, which currently comprises seven research laboratories.

The proposed center is expected to create employment opportunities for highly skilled professionals and add to Hyderabad's growing base of life sciences research and development activity.

Amgen operates across around 100 countries and regions and develops therapies in areas including oncology, cardiovascular diseases, bone health, inflammation, respiratory diseases, and rare diseases. The new center will bring together scientists and technologists working across discovery chemistry, drug metabolism and pharmacokinetics, and precision medicine.

Jay Bradner, executive vice president of Research and Development, Artificial Intelligence, and Data at Amgen, said the Genome Valley center would expand the company's ability to integrate experimental science with data and technology across its global research network while complementing its research operations in the US.